These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 28544443)
1. Development of a clinical trials version of the Impact of Weight on Quality of Life-Lite questionnaire (IWQOL-Lite Clinical Trials Version): results from two qualitative studies. Kolotkin RL; Ervin CM; Meincke HH; Højbjerre L; Fehnel SE Clin Obes; 2017 Oct; 7(5):290-299. PubMed ID: 28544443 [TBL] [Abstract][Full Text] [Related]
2. Validation of a new measure of quality of life in obesity trials: Impact of Weight on Quality of Life-Lite Clinical Trials Version. Kolotkin RL; Williams VSL; Ervin CM; Williams N; Meincke HH; Qin S; von Huth Smith L; Fehnel SE Clin Obes; 2019 Jun; 9(3):e12310. PubMed ID: 30993900 [TBL] [Abstract][Full Text] [Related]
3. Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample. Kolotkin RL; Crosby RD Qual Life Res; 2002 Mar; 11(2):157-71. PubMed ID: 12018739 [TBL] [Abstract][Full Text] [Related]
4. Development of a brief measure to assess quality of life in obesity. Kolotkin RL; Crosby RD; Kosloski KD; Williams GR Obes Res; 2001 Feb; 9(2):102-11. PubMed ID: 11316344 [TBL] [Abstract][Full Text] [Related]
5. Confirmatory psychometric evaluations of the Impact of Weight on Quality of Life-Lite Clinical Trials Version (IWQOL-Lite-CT). Kolotkin RL; Williams VSL; von Huth Smith L; Meincke HH; Qin S; Williams N; Fehnel SE Clin Obes; 2021 Oct; 11(5):e12477. PubMed ID: 34296522 [TBL] [Abstract][Full Text] [Related]
6. Psychometric evaluation of a Brazilian version of the impact of weight on quality of life (IWQOL-Lite) instrument. de A Mariano MH; Kolotkin RL; Petribú K; de N L Ferreira M; Dutra RF; Barros MV; Almeida NC; de L Filho LE; Rabelo PJ; Monteiro V; da Silva BF Eur Eat Disord Rev; 2010 Jan; 18(1):58-66. PubMed ID: 20054878 [TBL] [Abstract][Full Text] [Related]
7. Performance of a weight-related measure of Quality of Life in a psychiatric sample. Kolotkin RL; Crosby RD; Corey-Lisle PK; Li H; Swanson JM Qual Life Res; 2006 May; 15(4):587-96. PubMed ID: 16688492 [TBL] [Abstract][Full Text] [Related]
8. Psychometric evaluation of the German version of the impact of weight on Quality of Life-Lite (IWQOL-Lite) questionnaire. Mueller A; Holzapfel C; Hauner H; Crosby RD; Engel SG; Mühlhans B; Kolotkin RL; Mitchell JE; Horbach T; Zwaan Md Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):69-74. PubMed ID: 20658439 [TBL] [Abstract][Full Text] [Related]
9. Psychometric evaluation of the IWQOL-Lite (Spanish version) when applied to a sample of obese patients awaiting bariatric surgery. Andrés A; Saldaña C; Mesa J; Lecube A Obes Surg; 2012 May; 22(5):802-9. PubMed ID: 21898041 [TBL] [Abstract][Full Text] [Related]
10. The relationship between health-related quality of life and weight loss. Kolotkin RL; Crosby RD; Williams GR; Hartley GG; Nicol S Obes Res; 2001 Sep; 9(9):564-71. PubMed ID: 11557837 [TBL] [Abstract][Full Text] [Related]
11. Assessing weight-related quality of life in obese persons with type 2 diabetes. Kolotkin RL; Crosby RD; Williams GR Diabetes Res Clin Pract; 2003 Aug; 61(2):125-32. PubMed ID: 12951281 [TBL] [Abstract][Full Text] [Related]
12. Estimating a preference-based single index for the Impact of Weight on Quality of Life-Lite (IWQOL-Lite) instrument from the SF-6D. Brazier JE; Kolotkin RL; Crosby RD; Williams GR Value Health; 2004; 7(4):490-8. PubMed ID: 15449641 [TBL] [Abstract][Full Text] [Related]
13. Patient-reported quality of life in a randomized placebo-controlled trial of naltrexone/bupropion for obesity. Kolotkin RL; Chen S; Klassen P; Gilder K; Greenway FL Clin Obes; 2015 Oct; 5(5):237-44. PubMed ID: 26222044 [TBL] [Abstract][Full Text] [Related]
14. One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures. Kolotkin RL; Norquist JM; Crosby RD; Suryawanshi S; Teixeira PJ; Heymsfield SB; Erondu N; Nguyen AM Health Qual Life Outcomes; 2009 Jun; 7():53. PubMed ID: 19505338 [TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in two randomized controlled trials of phentermine/topiramate for obesity: What mediates improvement? Kolotkin RL; Gadde KM; Peterson CA; Crosby RD Qual Life Res; 2016 May; 25(5):1237-44. PubMed ID: 26446094 [TBL] [Abstract][Full Text] [Related]
16. Effect of once-weekly subcutaneous semaglutide 2.4 mg on weight- and health-related quality of life in an East Asian population: Patient-reported outcomes from the STEP 6 trial. Kolotkin RL; Jeppesen OK; Baker-Knight J; Lee SY; Tokita A; Kadowaki T Clin Obes; 2023 Aug; 13(4):e12589. PubMed ID: 36905345 [TBL] [Abstract][Full Text] [Related]
17. A systematic review of the quality of psychometric evidence supporting the use of an obesity-specific quality of life measure for use with persons who have class III obesity. Forhan M; Vrkljan B; MacDermid J Obes Rev; 2010 Mar; 11(3):222-8. PubMed ID: 19493301 [TBL] [Abstract][Full Text] [Related]
18. Content identification of the IWQOL-Lite with the International Classification of Functioning, Disability and Health. Tessier A; Mayo NE; Cieza A Qual Life Res; 2011 May; 20(4):467-77. PubMed ID: 21061070 [TBL] [Abstract][Full Text] [Related]
19. Assessing weight-related quality of life in adolescents. Kolotkin RL; Zeller M; Modi AC; Samsa GP; Quinlan NP; Yanovski JA; Bell SK; Maahs DM; de Serna DG; Roehrig HR Obesity (Silver Spring); 2006 Mar; 14(3):448-57. PubMed ID: 16648616 [TBL] [Abstract][Full Text] [Related]
20. Effect of semaglutide 2.4 mg on physical functioning and weight- and health-related quality of life in adults with overweight or obesity: Patient-reported outcomes from the STEP 1-4 trials. Rubino D; Bjorner JB; Rathor N; Sharma AM; von Huth Smith L; Wharton S; Wadden T; Zeuthen N; Kolotkin RL Diabetes Obes Metab; 2024 Jul; 26(7):2945-2955. PubMed ID: 38698650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]